Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsSecurities - Held-to-maturitySecurities - TradableShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capital Bancorp (CBNK) Cash & Equivalents (2017 - 2025)

Capital Bancorp (CBNK) has disclosed Cash & Equivalents for 9 consecutive years, with $255.6 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 24.46% to $255.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $255.6 million through Dec 2025, up 24.46% year-over-year, with the annual reading at $255.6 million for FY2025, 24.46% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $255.6 million at Capital Bancorp, up from $188.9 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $324.0 million in Q3 2021, with the low at $37.1 million in Q3 2022.
  • Average Cash & Equivalents over 5 years is $193.6 million, with a median of $186.1 million recorded in 2021.
  • The sharpest move saw Cash & Equivalents tumbled 88.56% in 2022, then soared 294.34% in 2023.
  • Over 5 years, Cash & Equivalents stood at $183.4 million in 2021, then plummeted by 56.15% to $80.4 million in 2022, then crashed by 32.89% to $54.0 million in 2023, then skyrocketed by 280.5% to $205.3 million in 2024, then rose by 24.46% to $255.6 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $255.6 million, $188.9 million, and $274.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.